Showing articles whose micro-themes are very close to:
#economic evaluation
- No closely related articles found yet.
- HIQA to assess COVID-19 vaccination strategies for Ireland (hiqa.ie) | 36d ago
- NCPE Releases Full HTA Submission Template Version 3.1 for Pharmacoeconomic Assessments in Ireland (ncpe.ie) | 629d ago
- Oireachtas Written Answer on Vaccine Cost-Effectiveness for Recombinant Zoster Vaccine (oireachtas.ie) | 18d ago
- NCPE Assessment: Belzutifan not cost-effective for VHL disease-associated tumours at current price (ncpe.ie) | 40d ago
- HIQA Publishes Health Technology Assessment of RSV Immunisation in Ireland (hiqa.ie) | 43d ago
- Cost-Effectiveness Evidence on Approved Cancer Drugs in Ireland (pmc.ncbi.nlm.nih.gov) | 18d ago
- HIQA publishes health technology assessment on RSV immunisation in Ireland (hiqa.ie) | 43d ago
- HIQA 2023 HTA Impact Report: Knowledge Sharing and Influence on Irish Health Policy (hiqa.ie) | 18d ago
- Scoping review: Association between herpes zoster vaccination and dementia risk (hiqa.ie) | 22d ago
- HIQA Protocol for Health Technology Assessment of COVID-19 Vaccination in Ireland (hiqa.ie) | 36d ago
- Reimbursement dispute over prostate cancer drug delays patient access (medicalindependent.ie) | 15d ago
- HIQA Rapid Health Technology Assessment of RSV Immunisation for Infants and Older Adults in Ireland (hiqa.ie) | 666d ago
Showing page 1 of 1
(12 total results)
← Prev
Next →